NCT00116493|CompletedPhase 3DMC
Severe Anemia Treatment Trials, Pakistan
Evaluation of Anthelminthics and Multivitamins for Treatment of Severe Anemia in Pregnant Women and Children 6-24 Months of Age in Pakistan
Loading search results
Sponsor study identifier
Secondary identifiers
interventional
1,009
1 country
1
Study Start
April 2004
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
May 2007
Actual (reported)Study Completion
May 2007
Actual (reported)The purpose of this study is to test the efficacy of two enhanced regimens (deworming and multivitamins) in the treatment of severe anemia in pregnant women and children 6-24 months of age in Karachi, Pakistan.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
May 2007
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
April 2004
Date type not reportedThis date has not been verified as actual or estimated.
June 29, 2005
Actual (reported)June 30, 2005
Actual (reported)May 2007
Actual (reported)May 2007
Actual (reported)Severe Anemia
Standard of care (Iron-folic acid + Deworming)
100 mg iron for pregnant women, 25 mg iron for children 1 mg of folic acid for pregnant women, 100 ug folic acid for children 500 mg of mebendazole for both pregnant women and children
100 mg twice a day for 3 days; Iron-folic acid also given
These entries preserve how the registry describes the intervention. Their treatment roles are shown separately from molecular identities.
Grouped treatment entry
Iron-folic acid and mebendazole
The registry names several treatments. This does not confirm that participants received them together or that they form a single product.
View registry recordPartially structured registry wording
Mebendazole + Multivitamin
Part of this registry label remains unresolved and is preserved as written. Recognized names are text references, not confirmed ingredients. Composition, doses and actual exposure are not established.
Names joined in the label
1 recognized name reference in the wording; 1 unresolved part.
Aga Khan University
Karachi, Sindh, Pakistan
Bhutta Z, Klemm R, Shahid F, Rizvi A, Rah JH, Christian P. Treatment response to iron and folic acid alone is the same as with multivitamins and/or anthelminthics in severely anemic 6- to 24-month-old children. J Nutr. 2009 Aug;139(8):1568-74. doi: 10.3945/jn.108.103507. Epub 2009 Jun 17.
Christian P, Shahid F, Rizvi A, Klemm RD, Bhutta ZA. Treatment response to standard of care for severe anemia in pregnant women and effect of multivitamins and enhanced anthelminthics. Am J Clin Nutr. 2009 Mar;89(3):853-61. doi: 10.3945/ajcn.2008.26826. Epub 2009 Jan 28.
Parul Christian, DrPH
Johns Hopkins Bloomberg School of Public Health
1,009 participants (actual enrollment reported by the registry).
First Submitted
June 29, 2005
First Posted
June 30, 2005
Study Start
April 2004
Date type not reportedThis date has not been verified as actual or estimated.
Iron-folic acid also given; Includes vitamins A, C, B12, E, and B2
Multivitamins + Mebendazole at 100 mg twice a day for 3 days; Iron-folic acid also given
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to confirm eligibility.
Primary Completion
May 2007
Actual (reported)Study Completion
May 2007
Actual (reported)Last Updated
April 9, 2012
Record last verified: 2012-04
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: